Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women. (Q51587320)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women. |
scientific article published in February 2010 |
Statements
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women. (English)
1 reference
José Garcia-Sicilia
1 reference
Tino F Schwarz
1 reference
Alfonso Carmona
1 reference
Klaus Peters
1 reference
Jean-Elie Malkin
1 reference
Phu M Tran
1 reference
Ulrich Behre
1 reference
Enrique B Iturbe
1 reference
Gregory Catteau
1 reference
Florence Thomas
1 reference
Kurt Dobbelaere
1 reference
Dominique Descamps
1 reference
Gary Dubin
1 reference
HPV Vaccine Adolescent Study Investigators Network
1 reference
1 February 2010
1 reference
46
1 reference
2
1 reference
142-151
1 reference